0001183740-17-000158.txt : 20170911 0001183740-17-000158.hdr.sgml : 20170911 20170908201819 ACCESSION NUMBER: 0001183740-17-000158 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170911 DATE AS OF CHANGE: 20170908 EFFECTIVENESS DATE: 20170911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProMIS Neurosciences Inc. CENTRAL INDEX KEY: 0001374339 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-293125 FILM NUMBER: 171077694 BUSINESS ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 BUSINESS PHONE: 416-847-6898 MAIL ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 FORMER COMPANY: FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD DATE OF NAME CHANGE: 20060831 D/A 1 primary_doc.xml X0708 D/A LIVE 0001374339 ProMIS Neurosciences Inc. SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 416-847-6898 CANADA (FEDERAL LEVEL) AMORFIX LIFE SCIENCES LTD Corporation true Elliot Goldstein Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director Neil Cashman Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director Patrick D. Kirwin Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Johannes Roth Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Eugene Williams Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director William Wyman Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Richard Gregory Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Anthony Giovinazzo Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Janet Clennett Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Johanne Kaplan Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Biotechnology Decline to Disclose 06b true 0001183740-17-000149 2017-08-09 true true true true true Units at C$0.25 per Unit (comprised of one common share and one-half of one common share purchase warrant, exercisable into a share at C$0.30 for five years.) false 0 Noble Capital Markets, Inc. 15768 None None 225 NE Mizner Blvd, Suite 150 Boca Raton FL FLORIDA 33432 CA CALIFORNIA FL FLORIDA MA MASSACHUSETTS NY NEW YORK false 1126497 704061 422436 The Offering Amount equals price of units (3,520,306 units x C$0.25 (US$0.20)) plus aggregate exercise price of warrants forming part of the units (1,760,153 warrants x C$0.30 (US$0.24)). Amount Sold equals price of units sold on 8/9/2017 and 8/28/2017. false 15 44066 true 0 Placement fees in the amount of US$44,066.15 representing 7% of the gross proceeds from the sale of Units. Noble Capital Markets Inc. also received 220,330 warrants, exercisable at C$0.285 per share for five years. 0 false ProMIS Neurosciences Inc. /s/ Elliot Goldstein Elliot Goldstein President and CEO 2017-09-08